Serum Potassium and Mortality in High-Risk Patients: SPRINT
4.6 (581) · € 28.50 · En Stock
Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: modelling study
Empowering the Pharmacist to Improve Clinical and Economic Consequences of Diabetic Kidney Disease
Empowering the Pharmacist to Improve Clinical and Economic Consequences of Diabetic Kidney Disease
Abnormalities of Potassium in Heart Failure: JACC State-of-the-Art Review
All-cause and cardiovascular mortality after hypokalemia or borderline
Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: modelling study
Risk of Developing Hypokalemia in Patients With Hypertension Treated With Combination Antihypertensive Therapy
Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension - ScienceDirect
Serum potassium level, variability and in‑hospital mortality in acute myocardial infarction - Zhang - 2022 - European Journal of Clinical Investigation - Wiley Online Library
Clinical benefit of systolic blood pressure within the target range among patients with or without diabetes mellitus: a propensity score-matched analysis of two randomized clinical trials, BMC Medicine
Distribution and characteristics of the SPRINT patient population (n ¼
Current status of the rapid decline in renal function due to diabetes mellitus and its associated factors: analysis using the National Database of Health Checkups in Japan
